📰 Nancy Pryer News
Nancy Pryer News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Nancy Pryer. Real-time updates on events, politics, business and more.
January 7, 2022
Biotech startup Ambagon Therapeutics is taking a new approach to making elusive protein targets “druggable” by using molecular glues. The biotech has a pipeline of preclinical cancer drugs and it has raised $85 million to support their development.
January 7, 2022
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
January 6, 2022
Modular platform enables development of molecular glue stabilizers addressing intrinsically disordered proteins, a largely undrugged target classInitial discovery pipeline focused on high-value targets in oncologySAN FRANCISCO--(BUSINESS WIRE)--Ambagon Therapeutics, a biotechnology company unlocking intrinsically di...
January 6, 2022
Modular platform enables development of molecular glue stabilizers addressing intrinsically disordered proteins, a largely undrugged target class Initial discovery pipeline focused on high-value